500 Plaza Drive
29 articles with Quest Diagnostics
Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states
Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the market. With this backdrop, let’s look at some companies working in the same field as the now-defunct T...
Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year.
More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type
Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge
Quest Diagnostics Incorporated announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its India medical diagnostic service business to Strand Life Sciences, a Bangalore-based specialized diagnostics company.
Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis
Cocaine positivity increases nearly 43 percent in Retail, more than twice the overall increase of the general U.S. workforce
Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a survey conducted by Modern Healthcare Custom Media on behalf of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.
Quest Diagnostics to Build Flagship Laboratory at Visionary Campus in Clifton, New Jersey to Empower Better Health for Patients in Seven States
New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity
Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the Midwest
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of three studies at the 2018 American Heart Association Scientific Sessions in Chicago.
- Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participants
Quest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory services business of Oxford Immunotec.
Quest Diagnostics and Marin General Hospital to Improve Access to Innovative Diagnostic Services in Northern California
Quest to Acquire the Outreach Laboratory Service Operations of Marin General Hospital
Third quarter revenues of $1.89 billion, up 1.8% from 2017
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, November 29, 2018 at The InterContinental New York Times Square Hotel at 300 W. 44th St.
Quest Diagnostics to Present New Insights from Genetic Testing at the 2018 American Society of Human Genetics Annual Meeting
Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics
Bolsters company's expert screening and intervention services for employers and managed populations
Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World
The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation
As the timeline shortens for Albert Bourla to take over the reins of Pfizer from Chief Executive Officer Ian Read, the company has released details of the new senior management team that will continue to lead the company forward.